Delivery Order SPE2DR25D3504-SPE2DR26F7BK4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,760.29 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60gm), a topical pharmaceutical product. This firm fixed-price, non-set-aside contract was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60 grams) valued at $1,493.37 with an ultimate completion date of October 30, 2025. This is a firm fixed price, non-set-aside contract executed on October 29, 2025, with performance based in Conshohocken, Pennsylvania, the company's corporate headquarters location. The award represents a single delivery order under AmerisourceBergen's larger federal contracting relationships supporting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $40,234.19 for OPZELURA 1.5% Cream in a 60-gram quantity on December 8, 2025, with completion expected by December 9, 2025. This firm fixed-price contract was competitively awarded without set-aside provisions and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value...
- The Defense Logistics Agency awarded a delivery order valued at $3,430.79 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream 60GM on December 2, 2025, with an ultimate completion date of December 3, 2025. This firm fixed price contract represents a non-set-aside, competitively awarded procurement under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $3,855.66 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in 60-gram units under a firm fixed-price contract type. This award, issued on November 25, 2025, with an ultimate completion date of November 26, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor specializing...
- The Defense Logistics Agency awarded a delivery order valued at $9,046.93 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in 60-gram quantities on November 18, 2025, with completion scheduled for November 19, 2025. This firm fixed-price contract represents a non-competitive set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate headquarters location in...
- The Defense Logistics Agency awarded a delivery order valued at $5,875.38 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60GM) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,258.72 for OPZELURA 1.5% Cream 60GM on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single pharmaceutical product delivery under the company's larger contracting...
- The Defense Logistics Agency awarded a delivery order valued at $2,503.51 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in 60-gram quantities under a firm fixed-price contract. The award was made on August 28, 2025, with an ultimate completion date of August 29, 2025, with no set-aside designation applied. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $16,474.15 delivery order to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in 60-gram units under a firm fixed-price contract. This non-set-aside delivery order was competitively awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- SPE2DR25D3504Indefinite Delivery Contract
- SPE2DR25D3504-SPE2DR26F7BK4Delivery Order
The Defense Logistics Agency awarded a $1,702.92 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for OPZELURA 1.5% Cream in 60-gram quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 4, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide, enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's significant presence in federal medical procurement and its competitively awarded contract portfolio demonstrate the company's established capability to meet DLA's pharmaceutical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/2/25 |